PharmaBoardroom

Speeding up Regulatory Submissions Through Continuous Publishing

Veeva Systems Europe’s Paul Attridge highlights how a switch to a continuous model for regulatory operations could allow biopharmaceutical companies…

US Pharma Could do a Lot More to Embrace the Consumer

PwC's Kelly Barnes examines how the US pharmaceutical sector is having to rethink its relationship with consumers, experimenting with new and…

Vaccine Hesitancy and the Threat to Global Health Security

MSD's Cyril Schiever outlines why vaccine hesitancy is such a threat to global health, the misinformation around vaccines being spread online, and how…

Why Pharma Needs Transformational Leaders

Rodrigo Araujo of global organizational consulting firm Korn Ferry outlines what he sees as the leadership profile of the future - agile, digital,…

Rosa Gonzalez Galindo – Senior Vice President of Clinical…

Through a merger between INC Research and inVentiv Health in 2018, Syneos Health has become the industry’s only fully integrated biopharmaceutical…

Cannabinoid Drugs, Medicinal Cannabis and Opioid Drugs: Ukraine

The legal framework for cannabinoid drugs, medicinal cannabis and opioid drugs in Ukraine. Prepared in association with Sayenko Kharenko, a leading…

Regulatory Reforms: Ukraine

An insight into regulatory reforms in Ukrainian pharma. Prepared in association with Sayenko Kharenko, a leading law firm in Ukraine, this is an…

US-China Tensions Heating Up in the Life Sciences

Eurasia Group’s Aditya Bhattacharji looks at the potentially damaging fallout of the ongoing US-China trade war on the life sciences industry.…

Marco Monrouzeau – General Manager and CFO, Neolpharma…

Marco Monrouzeau is the general manager and CFO of the Puerto Rican affiliate of Mexican drug maker Neolpharma, which has manufacturing operations at…